secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001171520-21-000516
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro Q3 revenue $4.6M record, up 30% YoY; reaffirms FY guidance
---------------------------------------------------------------------------

- Record revenue $4.6M (+30% YoY); biologics/drug delivery $2.1M (+39%).
- Functional neurosurgery revenue $2.2M (+17%); capital equipment $0.4M (+78%).
- Gross margin 68% vs 74% due to inventory reserves and overhead.
- R&D spend $2.6M (+130%) driven by headcount and platform expansion.
- Cash $57.7M; guidance: FY revenue $16-17.5M, case volume 900-1000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152021000516/0001171520-21-000516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152021000516/eps9899.htm
  HTML page:      https://secwatch.observer/filing/0001171520-21-000516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer